Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Azelaic/Salicylic Acid vs TCA Peel in Acne
NCT03071549Phase 3Completed
- Sponsor
- Cairo University
- Start
- Apr 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of Azelaic acid and Salvax in acne vulgaris (2 arms), sponsored by Cairo University. Primary endpoint: Change in acne lesions count at 8 weeks. Started Apr 2016; status: completed.
02
Drugs
Azelaic acidSalvax
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03071549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03071549.